DIADEMA PARTNERS LP
Q4 2024 13F Holdings
- Locationmorristown, NJ
- Num holdings
107
- Value ($000)
$233,054
- Date Filed02/14/2025
- Form type13F-HR
- CIK0002026172
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
VRTX VERTEX PHARMACEUTICALS INC | COM | 92532F100 | $23.11M | 10 % | 57,400 | call | |
KRE SPDR SER TR | S&P BIOTECH | 78464A870 | $18.01M | 8 % | 200,000 | put | |
BMY BRISTOL-MYERS SQUIBB CO | COM | 110122108 | $9.05M | 4 % | 160,000 | ||
ABBV ABBVIE INC | COM | 00287Y109 | $8.88M | 4 % | 50,000 | ||
ABBV ABBVIE INC | COM | 00287Y109 | $8.88M | 4 % | 50,000 | put | |
SOLENO THERAPEUTICS INC | COM | 834203309 | $7.88M | 3 % | 175,400 | put | |
ACLX ARCELLX INC | COMMON STOCK | 03940C100 | $7.67M | 3 % | 100,000 | put | |
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | $7.51M | 3 % | 190,800 | call | |
TEVA TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | $6.68M | 3 % | 300,000 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | $6.02M | 3 % | 200,000 | put |
Rows Per Page
1 - 10 of 10710
- 10
- 50
- 100